Inmune Bio (INMB) Return on Assets (2019 - 2025)
Historic Return on Assets for Inmune Bio (INMB) over the last 6 years, with Q3 2025 value amounting to 1.45%.
- Inmune Bio's Return on Assets fell 6600.0% to 1.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.45%, marking a year-over-year decrease of 6600.0%. This contributed to the annual value of 0.88% for FY2024, which is 4500.0% down from last year.
- Latest data reveals that Inmune Bio reported Return on Assets of 1.45% as of Q3 2025, which was down 6600.0% from 1.49% recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Return on Assets ranged from a high of 0.09% in Q1 2021 and a low of 1.49% during Q2 2025
- Its 5-year average for Return on Assets is 0.57%, with a median of 0.36% in 2023.
- Per our database at Business Quant, Inmune Bio's Return on Assets crashed by -100bps in 2023 and then plummeted by -7300bps in 2025.
- Quarter analysis of 5 years shows Inmune Bio's Return on Assets stood at 0.28% in 2021, then dropped by -12bps to 0.31% in 2022, then crashed by -59bps to 0.5% in 2023, then plummeted by -86bps to 0.92% in 2024, then tumbled by -57bps to 1.45% in 2025.
- Its Return on Assets stands at 1.45% for Q3 2025, versus 1.49% for Q2 2025 and 1.07% for Q1 2025.